Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype.
Helicobacter pylori infection is linked to the development of gastric cancer. Atrophic body gastritis is considered the first important step in the histogenesis of such neoplasia. H. pylori infection is involved in the induction of atrophic body gastritis, but documentation of H. pylori infection is difficult because of the progressive disappearance of the bacterium. Host-pathogen interactions may be investigated by means of immunoproteomics, which provides global information regarding the host humoral response to H. pylori infection and allows the identification of relevant specific and nonspecific antigens, and can be used for diagnostic or prognostic purposes. In the present review, we describe how several research groups used H. pylori immunoproteomics to investigate highly immunoreactive bacterial antigens related to the development of gastric cancer.
Lahner
Edith
E
Digestive and Liver Disease Unit, University La Sapienza, Dipartimento di Scienze Cliniche, Ospedale Sant'Andrea, Rome, Italy.
Bernardini
Giulia
G
Santucci
Annalisa
A
Annibale
Bruno
B
D000818:Animals; D002277:Carcinoma / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D005756:Gastritis / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*; D016480:Helicobacter pylori / Q000472:pathogenicity*; D006801:Humans; D008954:Models, Biological; D040901:Proteomics / Q000379:methods*; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology*